News & Events

Amphastar Intranasal Naloxone Delay

Amphastar Naloxone Intranasal Approval In a disappointing press release issued February 21, 2017, pharmaceutical company Amphastar announced that its New Drug Application for Intranasal Naloxone received a Complete Response Letter from the U.S. Food and Drug...

read more

ResQ Pharma Raises $725,000

ResQ Pharma, Inc., a biopharmaceutical company focused on commercializing LipidRescue™ Therapy (LRT), which is a treatment for various drug overdoses and poisonings, announces the completion of a second seed-round of equity financing of $725,000.00.

read more

Guy Weinberg Presents at EAPCCT

ResQ Pharma, Inc., a biopharmaceutical company focused on ensuring reliable, global use of LipidRescue™ Therapy (LRT), a treatment for various lipophilic drug overdoses & poisonings, today announced that Guy Weinberg, M.D., its co-founder and inventor of LRT will be presenting this Friday, May 27th at the Congress Of The European Association Of Poisons Centres And Clinical Toxicologists

read more